Use of CT-scan score and volume measures to early identify restrictive allograft syndrome in single-lung transplant recipients
The Journal of Heart and Lung Transplantation Dec 05, 2019
Philippot Q, Debray MP, Bun R, et al. - Via studying single-lung transplantation (SLTx) cohort with chronic lung allograft dysfunction (CLAD), researchers examined whether CT-score/volume measures and functional spirometric criteria, both, could assist in early identification of restrictive allograft syndrome (RAS) in this population. Fifty-one SLTx patients were assessed (17 RAS, 17 bronchiolitis obliterans syndrome [BOS], 17 stable condition). In SLTx, criteria for RAS diagnosis included FVC < 80% baseline (BL) or FEV1 < 80%BL with FEV1/FVC ratiounchanged or > 0.7 and persistent CT-scan-lung opacities. Four-time points (T) were defined: T-baseline, T-onset (first CT-scan-opacities), T-follow-up, and T-last. In RAS patients, only 47% achieved spirometric criteria for RAS at T-onset (FVC decline < 80%BL [29%] or FEV1 < 80%BL/ratiounch or > 0.7 [41%]), whereas at the same T-onset date, graft CT-score was raised to 5 [4-6] vs 1 [0-2] at baseline (CT-score ≥ 2 at T-onset in 100% and ΔCT-score ≥ 2 in 74% of RAS patients), and median CT-scan graft-volume reduced to 1,722 ml (vs 1,796 ml at T-baseline) (reduced CT-graft-volume < 90%BL in 50% of patients). In contrast, no change in CT-score/volume was observed at T-onset vs T-baseline in BOS patients. As per these findings, a simple CT-score and to a lesser extent CT-volume measures may assist in early identification and/or prediction of RAS in SLTx rather than functional criteria.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries